Psilocybin Therapy For Autism-Like Disorder Receives Approval For Phase 2a Clinical Trial Dec 28, 2022
Gilgamesh Pharmaceuticals Raises $39 Million To Develop Psychedelic Treatments For Depression Dec 20, 2022
Numinus In Strong Position To Capture US$2.5 Billion Psychedelic-Assisted Therapy Market Dec 20, 2022
